| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRM1
|
adhesion regulating molecule 1
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
ANXA2
|
annexin A2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
APPL2
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
|
|
AR
|
androgen receptor
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
AVP
|
arginine vasopressin
|
|
B2M
|
beta-2-microglobulin
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLDN11
|
claudin 11
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DEFB126
|
defensin, beta 126
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DYSF
|
dysferlin
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
EPHA2
|
EPH receptor A2
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FERMT1
|
fermitin family member 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FTO
|
fat mass and obesity associated
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALR1
|
galanin receptor 1
|
|
GAS6
|
growth arrest-specific 6
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTT
|
huntingtin
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSM1
|
insulinoma-associated 1
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB1BP2
|
integrin beta 1 binding protein (melusin) 2
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KATNAL2
|
katanin p60 subunit A-like 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LMNA
|
lamin A/C
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR1275
|
microRNA 1275
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MSH2
|
mutS homolog 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NUDT9
|
nudix (nucleoside diphosphate linked moiety X)-type motif 9
|
|
OCLN
|
occludin
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAX6
|
paired box 6
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLD4
|
polymerase (DNA-directed), delta 4, accessory subunit
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRNP
|
prion protein
|
|
PRTN3
|
proteinase 3
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RB1
|
retinoblastoma 1
|
|
RBM10
|
RNA binding motif protein 10
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERAC1
|
serine active site containing 1
|
|
SFTPD
|
surfactant protein D
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIGLEC9
|
sialic acid binding Ig-like lectin 9
|
|
SIRT2
|
sirtuin 2
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TDGF1P3
|
teratocarcinoma-derived growth factor 1 pseudogene 3
|
|
TFAP2E
|
transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM2
|
transglutaminase 2
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP53AIP1
|
tumor protein p53 regulated apoptosis inducing protein 1
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF2
|
WAS protein family, member 2
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
